Grand Pharmaceutical...
SEHK:512
HK$ 6,86
HK$-0,01 (-0,15%)
6,86 HK$
HK$-0,01 (-0,15%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

HK$0,35
Earnings Per Share
HK$3,51
Revenue Per Share
55,20%
Gross Margin %
HK$24,02 B
Market Cap
HK$1,84 B
Long-Term Debt
Earnings Per Share
HK$0,35
Revenue Per Share
HK$3,51
Gross Margin %
55,20%
Market Cap
HK$24,02 B
Long-Term Debt
HK$1,84 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2012 2010
EPS Earnings Per Share HK$0,35 HK$0,70 HK$0,54 HK$0,59 HK$0,68 HK$0,52 HK$0,35 HK$0,27 HK$0,19 HK$0,12 HK$0,03 HK$0,07
Earnings Earnings HK$1,23B HK$2,45B HK$1,89B HK$2,08B HK$2,40B HK$1,85B HK$1,18B HK$846,40M HK$425,03M HK$268,44M HK$58,86M HK$134,46M
RPS Revenue Per Share HK$0,00 HK$3,51 HK$3,33 HK$3,01 HK$2,72 HK$2,44 HK$1,79 HK$1,95 HK$1,90 HK$2,13 HK$0,00 HK$0,00 HK$0,00
Revenue Revenue HK$0,00M HK$12,28B HK$11,64B HK$10,53B HK$9,56B HK$8,60B HK$6,35B HK$6,59B HK$5,96B HK$4,77B HK$0,00M HK$0,00M HK$0,00M
OCF Operating Cash Flow HK$0,00M HK$2,46B HK$1,90B HK$2,42B HK$1,84B HK$2,01B HK$1,46B HK$1,29B HK$0,00M HK$719,72M HK$0,00M HK$0,00M HK$0,00M
FCF Free Cash Flow HK$0,00M HK$2,29B HK$1,34B HK$1,94B HK$1,22B HK$1,53B HK$0,00M HK$0,00M HK$0,00M HK$0,00M HK$0,00M HK$0,00M HK$0,00M
OM Operating Margin 0,00% 14,41% 19,07% 27,16% 28,74% 25,24% 28,07% 21,38% 14,98% 13,96% 12,38% 7,15% 4,41%
GM % Gross Margin % 0,00% 55,20% 57,86% 61,96% 62,24% 61,03% 63,52% 61,32% 53,06% 51,97% 46,87% 31,33% 35,54%
FCFS Free Cash Flow Per Share HK$0,00 HK$0,00 HK$0,37 HK$0,55 HK$0,22 HK$0,41 HK$0,35 HK$0,22 HK$0,40 HK$0,17 HK$0,19 HK$-0,23 HK$0,08
LT Debt Long-Term Debt N/A HK$1,84B HK$1,26B HK$990,03M HK$1,16B HK$1,51B HK$798,56M HK$1,06B HK$301,05M HK$691,64M HK$1,12B HK$135,23M HK$52,58M
Sha. Stocks 3.501,81M 3.500,85M 3.501,81M 3.501,81M 3.519,27M 3.527,14M 3.549,57M 3.377,57M 3.134,83M 2.237,01M 2.237,01M 1.962,04M 1.920,8M
×